| # | Drug | Count |
|---|---|---|
| 0 | DOCETAXEL | 290 |
| 1 | DOCETAXEL ANHYDROUS | 290 |
| 2 | ADALIMUMAB | 140 |
| 3 | DUPILUMAB | 107 |
| 4 | TRASTUZUMAB | 106 |
| 5 | CARBOPLATIN | 87 |
| 6 | INFLIXIMAB | 79 |
| 7 | METHOTREXATE SODIUM | 68 |
| 8 | PEGFILGRASTIM | 67 |
| 9 | CYCLOPHOSPHAMIDE | 65 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | PHENOXYBENZAMINE HYDROCHLORIDE | 1 | 0.0370 |
| 1 | BARICITINIB | 49 | 0.0161 |
| 2 | RITLECITINIB | 31 | 0.0158 |
| 3 | CALCIUM CARBONATE ANTACID | 1 | 0.0130 |
| 4 | MALATHION | 1 | 0.0099 |
| 5 | SORBITOL | 5 | 0.0083 |
| 6 | EPINASTINE HYDROCHLORIDE | 9 | 0.0079 |
| 7 | PEGFILGRASTIM | 67 | 0.0056 |
| 8 | CASTOR OIL | 1 | 0.0052 |
| 9 | DOCETAXEL | 290 | 0.0043 |
| # | Drug class | Count |
|---|---|---|
| 0 | Microtubule Inhibitor [EPC] | 294 |
| 1 | Tumor Necrosis Factor Blocker [EPC] | 151 |
| 2 | Corticosteroid [EPC] | 138 |
| 3 | Nonsteroidal Anti-inflammatory Drug [EPC] | 120 |
| 4 | HER2/neu Receptor Antagonist [EPC] | 107 |
| 5 | Interleukin-4 Receptor alpha Antagonist [EPC] | 107 |
| 6 | Platinum-based Drug [EPC] | 88 |
| 7 | Benzodiazepine [EPC] | 77 |
| 8 | Alkylating Drug [EPC] | 69 |
| 9 | Folate Analog Metabolic Inhibitor [EPC] | 62 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Microtubule Inhibitor [EPC] | 294 | 0.0018 |
| 1 | HER2/neu Receptor Antagonist [EPC] | 107 | 0.0014 |
| 2 | alpha-Hydroxy Acid [EPC] | 2 | 0.0009 |
| 3 | CD52-directed Cytolytic Antibody [EPC] | 12 | 0.0006 |
| 4 | Carnitine Analog [EPC] | 2 | 0.0005 |
| 5 | Noncompetitive AMPA Glutamate Receptor Antagonist [EPC] | 4 | 0.0005 |
| 6 | Interleukin-17 Receptor A Antagonist [EPC] | 1 | 0.0005 |
| 7 | Potassium-sparing Diuretic [EPC] | 6 | 0.0004 |
| 8 | Interleukin-13 Antagonist [EPC] | 3 | 0.0004 |
| 9 | Aromatase Inhibitor [EPC] | 50 | 0.0004 |